BRAINLIFE Brain Tumor Medical Database

Treatment > Radiotherapy


J Neurol Neurosurg Psychiatry. 2005 Nov 23; [Epub ahead of print]. (Clinical Study)


Abstract

Inter-institutional variance of postoperative radiotherapy and follow up for meningiomas in Germany. Impact of changes of the WHO classification

Simon M, Bostrom J, Koch P, Schramm J

Neurochirurgische Klinik, Universitatsklinikum Bonn, Germany.

Objective. To document and critically analyze the impact of the revised WHO 2000 histological classification for meningiomas on indications for postoperative radiotherapy/radiosurgery and MRI follow-up protocols. 

Methods. The current (2000) WHO classification was used to grade 57 meningiomas operated at our institution, which had previously been reviewed in 1999. 
All German Neurosurgical Departments performing intracranial microsurgery were asked to detail their guidelines for radiation therapy and follow-up for meningiomas of different WHO grades. 

Results. Use of the current criteria downgraded 7/15 (47%) atypical (WHO grade II, MII) meningiomas to grade I (MI), and 4/6 (67%) anaplastic (WHO grade III, MIII) tumors to grade II. 
Indications for radiotherapy/radiosurgery and MRI follow-up protocols varied substantially with the histological grade and between institutions. 
E.g. after an incomplete resection, radiotherapy/radiosurgery recommendations differed between MI and MII in 30/58 (52%), and between MII and MIII in 34/56 (61%) units. 

Conclusions. Correlative studies combining treatment and outcome data with a standardized histopathological analysis are warranted to properly define indications for radiotherapy/radiosurgery and follow-up protocols after surgery for meningiomas of different histological grades. 
The use of changing grading paradigms during recent years renders decision making based on local and published experience difficult. 
The relatively high number of meningiomas classified as atypical/WHO grade II in current practice would argue against an uncritically aggressive approach to these tumors.


PMID: 16306156 [PubMed - as supplied by publisher]
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16306156&query_hl=4
PDF Full Text: http://jnnp.bmjjournals.com/cgi/rapidpdf/jnnp.2005.077974v2


 

This website is certified by Health On the Net Foundation. Click to verify. HOMECURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTSBRAIN TUMOR MEDICAL DATABASE SERVICES TREATMENT OPTIONS FOR GLIOBLASTOMA
DATABASE by Section: Classification | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Management | Prognosis | Psychosocial Aspects | Stem Cells | Treatment
DATABASE by Tumor: Glioblastoma | Medulloblastoma | Other TumorsSERVICES: About BrainLife | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications | Search | SiteMap
This site complies with the HONcode standard for trustworthy health information: verify here bottom